IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines

Vaccine

Volumn 17, Issue 15-16, 1999, Pages 1889-1897

  Soininen, A ^a   Seppala I ^b   Nieminen, T ^a   Eskola, J ^a   Kayhty H ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Antibodies; IgG subclasses; Pneumococcal vaccination

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIAL VACCINE; DIPHTHERIA TOXIN; IMMUNOGLOBULIN G ANTIBODY; PNC CRM; PNC D; PNC T; PNEUMOCOCCUS VACCINE; TETANUS TOXIN; UNCLASSIFIED DRUG;

ADULT; ANTIBODY RESPONSE; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CLINICAL TRIAL; DIPHTHERIA; DRUG CONJUGATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; SUBCUTANEOUS DRUG ADMINISTRATION; TETANUS; TREATMENT OUTCOME; VACCINATION;

ADULT; ANALYSIS OF VARIANCE; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; DIPHTHERIA TOXOID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; POLYSACCHARIDES, BACTERIAL; STREPTOCOCCUS PNEUMONIAE; TETANUS TOXOID; TIME FACTORS; VACCINES, CONJUGATE;

EID: 0345472113     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00475-7     Document Type: Article

References (51)

1. Eskola J., Takala A., Kela E., Pekkanen E., Kalliokoski R., Leinonen M. Epidemiology of invasive pneumococcal infections in children in Finland. JAMA. 68:1992;3323.
2. Gray B.M., Converse G.M., Dillon H.C. Epidemiologic studies of Streptococcus pneumoniae in infants: aquisition, carriage, and infection during the first 24 months of life. J. Infect. Dis. 142:1980;923.
3. Klein J.O. The epidemiology of pneumococcal disease in infants and children. Rev. Infect. Dis. 162:1990;1316.
4. Douglas R.M., Paton J.C., Duncan S.J., Hansman D.J. Antibody response to pneumococcal vaccination in children younger than five years of age. J. Infect. Dis. 148:1983;131.
5. Mond J.J., Lees A., Snapper C.M. T cell-independent antigens type 2. Annu. Rev. Immunol. 13:1995;655.
6. Stein K.E. Thymus-independent and thymus-dependent responses to polysaccharide antigens. J. Infect. Dis. 165 (Suppl. 1):1992;S49.
7. Barrett D.J., Ayoub E.M. IgG2 subclass restriction of antibody to pneumococcal polysaccharides. Clin. Exp. Immunol. 63:1986;127.
8. Sarvas H., Rautonen N., Sipinen S., Mäkelä O. IgG subclasses of pneumococcal antibodies: effect of allotype G2m(n). Scand. J. Immunol. 29:1989;229.
9. Siber G.R., Schur P.H., Aisenberg A.C., Weitzman S.A., Schiffman G. Correlation between serum IgG2 concentrations and the antibody response to bacterial polysaccharide antigens. N. Engl. J. Med. 303:1980;178.
10. Shackelford P.G., Nelson S.J., Palma A.T., Nahm M.H. Human antibodies to group A streptococcal carbohydrate. Ontogeny, subclass restriction, and clonal diversity. J. Immunol. 140:1988;3200.
11. Hammarström L., Smith C.I.E. IgG2 deficiency in a healthy blood donor. Concominant lack of IgG2, IgA and IgE immunoglobulins and specific anti-carbohydrate antibodies. Clin. Exp. Immunol. 51(3):1983;600.
12. Herrman D.J., Hamilton R.G., Barington T., Frasch C.E., Arakere G., Mäkelä O., Mitchell L.A., Nagel J., Rijkers G.T., Zegers B., Danve B., Ward J.I., Brown C.S. Quantitation of human IgG subclass antibodies to Haemophilus influenzae type b capsular polysaccharide. Results of an international collaborative study using enzyme immunoassay methodology. J. Immunol. Methods. 148:1992;101.
13. Hammarström L., Persson M.A.A., Smith C.I.E. Immunoglobulin subclass distribution of human anti-carbohydrate antibodies: aberrant pattern in IgA-deficient donors. Immunology. 54:1985;821.
14. Perlmutter R.M., Hansburg D., Briles D.E., Nicolotti R.A., Davie J.M. Subclass restriction of murine anti-carbohydrate antibodies. J. Immunol. 121:1978;566.
15. Der Balian G.P., Slack J., Clevinger B.L., Bazin H., Davie J.M. Subclass restriction of murine antibodies. III. Antigens that stimulate IgG3 in mice stimulate IgG2c in rats. J. Exp. Med. 152:1980;209.
16. Freijd A., Hammarström L., Persson M.A.A., Smith C.I.E. Plasma anti-pneumococcal antibody activity of the IgG class and subclasses in otitis prone children. Clin. Exp. Immunol. 56:1984;233.
17. Bardardottir E., Jonsson S., Jonsdottir I., Sigfusson A., Valdimarsson H. IgG subclass response and opsonization of Streptococcus pneumoniae after vaccination of healthy adults. J. Infect. Dis. 162:1990;482.
18. Oldfield S., Jenkins S., Yeoman H., Gray D., MacLennan I.C.M. Class and subclass anti-pneumococcal antibody responses in splenectomized patients. Clin. Exp. Immunol. 61:1985;664.
19. Mäkelä O., Mattila P., Rautonen N., Seppälä I., Eskola J., Käyhty H. Isotype concentrations of human antibodies to Haemophilus influenzae type b polysaccharide (Hib) in young adults immunized with the polysaccharide as such or conjugated to a protein (diphtheria toxoid). J. Immunol. 139:1987;1999.
20. Shackelford P.G., Granoff D.M., Nelson S.J., Scott M.G., Smith D.S., Nahm M.H. Subclass distribution of human antibodies to Haemophilus influenzae type b capsular polysaccharide. J. Immunol. 138:1987;587.
21. Rautonen N., Pelkonen J., Sipinen S., Käyhty H., Mäkelä O. Isotype concentrations of human antibodies to group A meningococcal polysaccharide. J. Immunol. 137:1986;2670.
22. Jelonek M.T., Chang S.-J., Chiu C.-Y., Park M.K., Nahm M.H., Ward J.I. Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide. Infect. Immun. 61:1993;5345.
23. Oxelius V.-A. IgG subclass levels in infancy and childhood. Acta Paediatr. Scand. 68:1979;23.
24. Yachie A., Konno A., Ohta K., Wada T., Seki H., Taniguchi N., Miyawaki T. Delineation of producing ability of IgG and IgA subclasses by naive B cells in newborn infants and adult individuals. Clin. Exp. Immunol. 102(1):1995;204.
25. Seppälä I.J.T., Routonen N., Sarnesto A., Mattila P.A., Mäkelä O. The percentages of six immunoglobulin isotypes in human antibodies to tetanus toxoid: standardization of isotype-specific second antibodies in solid-phase assay. Eur. J. Immunol. 14:1984;868.
26. Sarnesto A., Ranta S., Väänänen P., Mäkelä O. Proportions if Ig classes and subclasses in rubella antibodies. Scand. J. Immunol. 21:1985;275.
27. Morell A., Roth-Wicky B., Skvaril F. Immunoglobulin G subclass restriction of antibodies against hepatitis B surface antigen. Infect. Immun. 39:1983;565.
28. Seppälä I., Sarvas H., Mäkelä O., Mattila P., Eskola J., Käyhty H. Human antibody responses to two conjugate vaccines of Haemophilus influenzae type b saccharides and diphtheria toxin. Scand. J. Immunol. 28:1988;471.
29. Bredius R.G.M., Driedijk P.C., Schouten M.F.J., Weening R.S., Out T.A. Complement activation by polyclonal immunoglobulin G1 and G2 antibodies against Staphylococcus aureus, Haemophilus influenzae type b and tetanus toxoid. Infect. Immun. 60:1992;4838.
30. Amir J., Scott M.G., Nahm M.H., Granoff D.M. Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b. J. Infect. Dis. 162:1990;163.
31. Käyhty H., Mäkelä O., Eskola J., Saarinen L., Seppälä I. Isotype distribution and bactericidal activity of antibodies after immunization with Haemophilus influenzae type b vaccines at 18-24 months of age. J. Infect. Dis. 158:1988;973.
32. Lortan J., Kaniuk A., Monteil M. Relationship of in vitro phagocytosis of serotype 14 Streptococcus pneumoniae to specific class and IgG subclass antibody levels in healthy adults. Clin. Exp. Immunol. 91:1993;54.
33. Weinberg G., Granoff D., Nahm M., Shackelford P. Functional activity of different IgG subclass antibodies against type b capsular polysaccharide of Haemophilus influenzae. J. Immunol. 136:1986;4232.
34. Åhman H., Käyhty H., Tamminen P., Vuorela A., Malinkoski F., Eskola J. Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants. Pediatr. Infect. Dis. J. 15:1996;134.
35. Käyhty H., Åhman H., Rönnberg P.-R., Tiilikainen R., Eskola J. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. J. Infect. Dis. 172:1995;1273.
36. Anderson E.L., Kennedy D.J., Geldmacher K.M., Donnelly J., Mendelman P.M. Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. Pediatrics. 128:1996;649.
37. Dagan R., Melamed R., Zamir O., Leroy O. Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens. Pediatr. Infect. Dis. J. 16:1997;1053.
38. 197 vaccines: effect of saccharide size on immunogenicity and interactions with simultaneously administered vaccines. J. Infect. Dis. 176:1997;445.
39. Mäkelä O., Péterfy F., Outschoorn I.G., Richter A.W., Seppälä I. Immunogenic properties of α(1→6) dextran, its protein conjugates, and conjugates of its breakdown products in mice. Scand. J. Immunol. 19:1984;541.
40. Seppälä I., Pelkonen J., Mäkelä O. Isotypes of antibodies by plain dextran or a dextran-protein conjugate. Eur. J. Immunol. 15:1985;827.
41. Quataert S.A., Kirch C.S., Quackenbush Wiedl L.J., Phipps D.C., Strohmeyer S., Cimino C.O., Skuse J., Madore D.V. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S. Clin. Diagn. Lab. Immunol. 2:1995;590.
42. Soininen A., Seppälä I., Wuorimaa T., Käyhty H. Assignment of immunoglobulin G1 and G2 concentrations to pneumococcal capsular polysaccharides 3, 6B, 14, 19F and 23F in a pneumococcal reference serum 89-SF. Clin. Diagn. Lab. Immunol. 5:1998;561.
43. Nieminen T., Käyhty K., Virolainen A., Eskola J. Circulating antibody secreting cell response to parenteral pneumococcal vaccines as an indicator of a salivary IgA antibody response. Vaccine. 16:1998;313.
44. Nieminen T., Eskola J., Käyhty H. Pneumococcal conjugate vaccination in adults: circulating antibody secreting cell response and humoral antibody responses in saliva and in serum. Vaccine. 16:1998;630.
45. Sarvas H.O., Aaltonen L.M., Péterfy F., Seppälä I.J., Mäkelä O. IgG subclass distributions in anti-hapten and anti-polysaccharide antibodies induced by haptenated polysaccharides. Eur. J. Immunol. 13:1983;409.
46. Barington T., Juul L., Gyhrs A., Heilmann C. Heavy-chain isotype patterns of human antibody-secreting cells induced by Haemophilus influenzae type b conjugate vaccines in relation to age and preimmunity. Infect. Immun. 62:1994;3066.
47. Lucas A.H., Granoff D.M., Mandrell R.E., Connolly C.C., Shan A.S., Powers D.C. Oligoclonality of serum immunoglobulin G antibody responses to Streptococcus pneumoniae capsular polysaccharide serotypes 6B, 14, and 23F. Infect. Immun. 65:1997;5103.
48. Insel R., Anderson P. Oligosaccharide-protein conjugate vaccines induce and prime for oligoclonal IgG antibody responses to the Haemophilus influenzae type b capsular polysaccharide in human infants. J. Exp. Med. 163:1986;262.
49. Aalberse R.C., van der Gaag R., van Leeuwen J. Prolonged immunization results in a IgG4-restricted response. J. Immunol. 130:1983;722.
50. Englund J.A., Glezen W.P., Turner C., Harvey J., Thompson C., Siber G.R. Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenzae type b vaccines. J. Infect. Dis. 171:1995;99.
51. Malek A., Sager R., Kuhn P., Nicolaides K.H., Schneider H. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am. J. Reprod. Immunol. 36:1996;248.